LU59646A1 - - Google Patents

Info

Publication number
LU59646A1
LU59646A1 LU59646DA LU59646A1 LU 59646 A1 LU59646 A1 LU 59646A1 LU 59646D A LU59646D A LU 59646DA LU 59646 A1 LU59646 A1 LU 59646A1
Authority
LU
Luxembourg
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU59646A1 publication Critical patent/LU59646A1/xx

Links

Classifications

    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F27FURNACES; KILNS; OVENS; RETORTS
    • F27DDETAILS OR ACCESSORIES OF FURNACES, KILNS, OVENS OR RETORTS, IN SO FAR AS THEY ARE OF KINDS OCCURRING IN MORE THAN ONE KIND OF FURNACE
    • F27D11/00Arrangement of elements for electric heating in or on furnaces
    • F27D11/08Heating by electric discharge, e.g. arc discharge
    • CCHEMISTRY; METALLURGY
    • C21METALLURGY OF IRON
    • C21CPROCESSING OF PIG-IRON, e.g. REFINING, MANUFACTURE OF WROUGHT-IRON OR STEEL; TREATMENT IN MOLTEN STATE OF FERROUS ALLOYS
    • C21C5/00Manufacture of carbon-steel, e.g. plain mild steel, medium carbon steel or cast steel or stainless steel
    • C21C5/52Manufacture of steel in electric furnaces
    • C21C5/5252Manufacture of steel in electric furnaces in an electrically heated multi-chamber furnace, a combination of electric furnaces or an electric furnace arranged for associated working with a non electric furnace
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F27FURNACES; KILNS; OVENS; RETORTS
    • F27DDETAILS OR ACCESSORIES OF FURNACES, KILNS, OVENS OR RETORTS, IN SO FAR AS THEY ARE OF KINDS OCCURRING IN MORE THAN ONE KIND OF FURNACE
    • F27D11/00Arrangement of elements for electric heating in or on furnaces
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F27FURNACES; KILNS; OVENS; RETORTS
    • F27DDETAILS OR ACCESSORIES OF FURNACES, KILNS, OVENS OR RETORTS, IN SO FAR AS THEY ARE OF KINDS OCCURRING IN MORE THAN ONE KIND OF FURNACE
    • F27D3/00Charging; Discharging; Manipulation of charge
    • F27D3/18Charging particulate material using a fluid carrier

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Organic Chemistry (AREA)
  • Vertical, Hearth, Or Arc Furnaces (AREA)
  • Furnace Details (AREA)
  • Discharge Heating (AREA)
LU59646D 1968-10-17 1969-10-14 LU59646A1 (Direct)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR170197 1968-10-17

Publications (1)

Publication Number Publication Date
LU59646A1 true LU59646A1 (Direct) 1970-01-12

Family

ID=8655735

Family Applications (1)

Application Number Title Priority Date Filing Date
LU59646D LU59646A1 (Direct) 1968-10-17 1969-10-14

Country Status (10)

Country Link
US (1) US3610795A (Direct)
JP (1) JPS4829422B1 (Direct)
BE (1) BE739974A (Direct)
BR (1) BR6913348D0 (Direct)
DE (1) DE1952407B2 (Direct)
ES (1) ES372628A1 (Direct)
FR (1) FR1601438A (Direct)
GB (1) GB1252310A (Direct)
LU (1) LU59646A1 (Direct)
SE (1) SE364311B (Direct)

Families Citing this family (140)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3891427A (en) * 1972-10-12 1975-06-24 Lectromelt Corp Method for melting prereduced ore and scrap
SE378735B (Direct) * 1972-11-17 1975-09-08 Asea Ab
FR2220584B1 (Direct) * 1973-03-05 1976-05-21 Siderurgie Fse Inst Rech
US3939297A (en) * 1973-12-07 1976-02-17 Chase Brass & Copper Co., Incorporated Stoker feed system
SE7503782L (sv) * 1975-04-02 1976-10-03 Asea Ab Sett och anordning for smeltreduktion av finkornigt jernoxidhaltigt material
DE2632707C3 (de) * 1976-07-21 1983-04-07 Ernst Dipl.-Ing. 4006 Erkrath Beiersdorf Beschickungsanlage an Elektro-Lichtbogenöfen zur Zugabe von Legierungsmitteln und Zuschlagstoffen
US4133967A (en) * 1977-06-24 1979-01-09 The United States Of America As Represented By The Secretary Of The Interior Two-stage electric arc - electroslag process and apparatus for continuous steelmaking
US4447906A (en) * 1981-02-02 1984-05-08 Lectromelt Corporation Arc furnace for producing aluminum
SE8303372L (sv) * 1983-06-14 1984-12-15 Asea Ab Ugnsanordning for smeltning av metaller eller metallegeringar
AT384669B (de) * 1986-03-17 1987-12-28 Voest Alpine Ag Anlage zur herstellung von stahl aus schrott
CA1311787C (en) * 1986-06-24 1992-12-22 Masahisa Tate Method of bottom blowing operation of a steel making electric furnace
FR2705767B1 (fr) * 1993-05-27 1995-07-21 Lorraine Laminage Procédé et installation de production d'acier liquide à partir de matières ferreuses riches en matières carbonées.
DE4339226A1 (de) * 1993-11-15 1995-05-18 Mannesmann Ag Verfahren und Vorrichtung zur Wertstoffgewinnung
LU88517A7 (fr) * 1993-12-15 1996-02-01 Wurth Paul Sa Dispositif de chargement d'un four électrique
AT404841B (de) * 1995-04-10 1999-03-25 Voest Alpine Ind Anlagen Anlage und verfahren zum herstellen von eisenschmelzen
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
US7227011B2 (en) 1998-06-04 2007-06-05 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acid vaccines for prevention of flavivirus infection
EP1181492B1 (en) * 1999-05-18 2005-08-03 Danieli Technology, Inc. Electric arc furnace and method for continuous charging
EP1702983A3 (en) 2000-04-13 2007-01-10 Medical University of South Carolina Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof
EP1303502A2 (en) * 2000-07-06 2003-04-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Tetrahydrobenzothiazole analogues as neuroprotective agents
WO2002006534A2 (en) 2000-07-17 2002-01-24 Vanderbilt University Method of diagnosing pulmonary hypertension
AU2001296846B2 (en) 2000-10-12 2007-07-05 University Of Rochester Compositions that inhibit proliferation of cancer cells
AU2002303277A1 (en) * 2001-04-06 2002-10-21 Vladimir Larionov Artificial chromosomes that can shuttle between bacteria, yeast, and mammalian cells
CN1599622A (zh) * 2001-10-01 2005-03-23 范德比尔特大学 用钙调蛋白激酶ⅱ抑制剂治疗结构性心脏病中的心肌功能障碍
AU2002332027A1 (en) * 2001-10-04 2003-04-14 The Government Of The United States Of America, As Tandem repeat markers
DE60332756D1 (de) 2002-02-06 2010-07-08 Vicor Technologies Inc Anti-infarkt-moleküle
CA2489540A1 (en) 2002-06-14 2003-12-31 The Government Of The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Office Of Technology Transfer Methods of treating and preventing colitis involving il-13 and nk-t cells
AU2003257181A1 (en) 2002-08-05 2004-02-23 University Of Rochester Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
JP4915980B2 (ja) 2002-11-15 2012-04-11 エムユーエスシー ファウンデーション フォー リサーチ デベロップメント 補体レセプター2標的化補体調節因子
US7557092B2 (en) 2002-11-21 2009-07-07 University Of Utah Research Foundation Purinergic modulation of smell
WO2005069969A2 (en) 2004-01-21 2005-08-04 University Of Utah Research Foundation Mutant sodium channel nav1.7 and methods related thereto
AU2005220874B2 (en) 2004-03-04 2010-12-23 Vanderbilt University Cell-penetrating SOCS polypeptides that inhibit cytokine-induced signaling
EP1734821A4 (en) * 2004-04-14 2011-07-06 Uab Research Foundation ACTIVATORS OF HEXOSAMIN BINOSYNTHESIS AS AN INHIBITORS FOR INDUCED DAMAGE CAUSED BY ISCHEMIC SHOCK OR HEMORRHAGIC SHOCK
US20050244335A1 (en) * 2004-05-03 2005-11-03 Rinehart John J Methods and compositions related to increasing antitumor activity of chemotherapeutic agents
WO2005110463A1 (en) 2004-05-11 2005-11-24 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health Methods of inhibiting proinflammatory cytokine expression using ghrelin
WO2006083275A2 (en) 2004-05-21 2006-08-10 The Uab Research Foundation Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof
EP1811839A4 (en) * 2004-11-18 2008-08-06 Univ Rochester METHOD AND COMPOSITIONS IN CONNECTION WITH ESCULENTOSIDE A
US7786074B2 (en) 2004-12-21 2010-08-31 MUSC Foundation for Research Development Charleston Composition and methods for promoting wound healing and tissue regeneration
US9072716B2 (en) 2005-04-15 2015-07-07 The United States of America, as represented by the Secretary Department of Health by Human Servies Methods of treating and preventing inflammatory bowel disease involving IL-13 and NKT cells
ES2431315T3 (es) 2005-05-19 2013-11-26 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Epítopos funcionales del antígeno PsaA de Streptococcus pneumoniae y usos de los mismos
US8859585B2 (en) 2005-05-25 2014-10-14 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Scopolamine for the treatment of depression and anxiety
DK3467096T3 (da) 2005-06-07 2022-03-28 Dsm Nutritional Products Ag Eukaryote mikroorganismer til fremstilling af lipider og antioxidanter
US8080534B2 (en) 2005-10-14 2011-12-20 Phigenix, Inc Targeting PAX2 for the treatment of breast cancer
EP2402435A3 (en) 2005-10-14 2012-03-28 MUSC Foundation For Research Development Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
ES2661002T3 (es) 2005-12-29 2018-03-27 The Regents Of The University Of California Procedimientos y composiciones relacionadas con el dominio Kunitz I mutante de TFPI-2
JP2009523129A (ja) 2006-01-05 2009-06-18 ユニバーシティ オブ ユタ リサーチ ファウンデーション 神経系を標的する薬理学的物質の性質を改善することに関連する方法および組成物
JP5872751B2 (ja) * 2006-02-06 2016-03-01 バーナム インスティテュート フォー メディカル リサーチ 腫瘍および損傷のターゲティングに関する方法および組成物
US8470965B2 (en) * 2006-03-01 2013-06-25 University Of Utah Research Foundation Methods and compositions related to cyclic peptide synthesis
AU2007223427A1 (en) * 2006-03-01 2007-09-13 University Of Utah Research Foundation Methods and compositions related to cyclic peptide synthesis
US8603751B2 (en) 2006-03-02 2013-12-10 The Uab Research Foundation Mycobacterial disease detection, treatment, and drug discovery
WO2008008720A2 (en) 2006-07-10 2008-01-17 Synapsin Pharmaceuticals, Inc. Compositions and methods relating to solenopsins and their uses in treating neurological disorders and enhancing physical performance
WO2008016854A2 (en) 2006-08-02 2008-02-07 The Uab Research Foundation Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity
US20100190689A1 (en) 2006-09-21 2010-07-29 University Of Rochester Compositions and methods related to protein displacement therapy for myotonic distrophy
US8999317B2 (en) 2006-11-01 2015-04-07 University Of Rochester Methods and compositions related to the structure and function of APOBEC3G
WO2008073441A2 (en) 2006-12-11 2008-06-19 University Of Utah Research Foundation Compositions and methods for treating pathologic angiogenesis and vascular permeability
EP2101567A4 (en) 2007-01-18 2010-04-21 Univ Utah Res Found COMPOSITIONS AND METHODS FOR DETECTING, TREATING OR PREVENTING REDUCED STRESS
EP2117576B1 (en) 2007-02-08 2014-04-16 University Of Utah Research Foundation Methods and compositions related to inhibition of viral entry
MX2009010081A (es) 2007-03-22 2010-01-20 Univ Yale Metodos y composiciones relacionadas con los ribointerruptores (riboswitches) que controlan el corte y empalme (splicing) alternativo.
WO2009017863A2 (en) 2007-05-08 2009-02-05 Burnham Institute For Medical Research Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification
EP2155894A4 (en) 2007-05-09 2010-08-18 Burnham Inst Medical Research HOST PROTEINAS AS A TARGET FOR A THERAPEUTIC STRATEGY AGAINST VIRAL AND BACTERIAL DISEASES
AU2007353789B2 (en) 2007-05-23 2014-05-22 The Uab Research Foundation Detoxified pneumococcal neuraminidase and uses thereof
MX2009012773A (es) 2007-05-29 2009-12-16 Univ Yale Ribointerruptores y metodos y composiciones para usarse de y con ribointerruptores.
US20110130345A1 (en) 2007-06-21 2011-06-02 Baerbel Rohrer Alpha connexin c-terminal (act) peptides for treating age-related macular degeneration
TW200916113A (en) 2007-08-08 2009-04-16 Sod Conseils Rech Applic Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
US20110081317A1 (en) * 2007-08-08 2011-04-07 University Of Rochester Enhancing Gene Transfer
WO2009042294A2 (en) * 2007-08-10 2009-04-02 Burnham Institute For Medical Research Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof
EP2268664B1 (en) 2007-12-03 2017-05-24 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Doc1 compositions and methods for treating cancer
US20090233993A1 (en) * 2008-03-06 2009-09-17 Burnham Institute For Medical Research Compositions and methods for inhibiting gsk3 activity and uses thereof
EP2853897A1 (en) 2008-05-08 2015-04-01 University Of Utah Research Foundation Sensory receptors for chronic fatigue and pain and uses thereof
US20090291073A1 (en) * 2008-05-20 2009-11-26 Ward Keith W Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
CA2734322A1 (en) * 2008-08-15 2010-02-18 Georgetown University Na channels, disease, and related assays and compositions
EP2370080A1 (en) 2008-12-02 2011-10-05 University of Utah Research Foundation Pde1 as a target therapeutic in heart disease
US20100286762A1 (en) * 2009-03-18 2010-11-11 Musc Foundation For Research Development Compositions and Methods for Ameliorating Clinical Electrical Disturbances
EP2430161A1 (en) 2009-05-15 2012-03-21 Yale University Gemm riboswitches, structure-based compound design with gemm riboswitches, and methods and compositions for use of and with gemm riboswitches
WO2011020107A2 (en) 2009-08-14 2011-02-17 Georgetown University Compositions and methods for detection and treatment of breast cancer
WO2011022502A1 (en) 2009-08-18 2011-02-24 Georgetown University Boronic acid compositions and methods related to cancer
WO2011031974A1 (en) 2009-09-10 2011-03-17 Southern Research Institute Acridine analogs in the treatment of gliomas
WO2011088076A2 (en) 2010-01-12 2011-07-21 Yale University Structured rna motifs and compounds and methods for their use
EP2544715A2 (en) 2010-03-09 2013-01-16 Board Of Regents, University Of Texas System Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
US20110262347A1 (en) 2010-04-08 2011-10-27 The Salk Institute For Biological Studies Methods and compositions for enhanced delivery of compounds
WO2012021554A1 (en) 2010-08-09 2012-02-16 Yale University Cyclic di-gmp-ii riboswitches, motifs, and compounds, and methods for their use
WO2012082942A2 (en) 2010-12-15 2012-06-21 Neuroadjuvants, Inc. Neuropeptide analogs, compositions, and methods for treating pain
CN103841991B (zh) 2011-03-15 2018-03-27 犹他大学研究基金会 诊断和治疗血管相关黄斑病及其症状的方法
JP6205345B2 (ja) 2011-03-28 2017-09-27 ユニヴァーシティー オブ ユタ リサーチ ファウンデーション ウイルス侵入の阻害に関する方法および組成物
WO2013036636A1 (en) 2011-09-06 2013-03-14 Dana-Farber Cancer Institute, Inc. Compositions and methods of treating cancer
EP2870238A4 (en) 2012-07-05 2016-03-09 Ohio State Innovation Foundation COMPOSITIONS AND METHODS RELATED TO VIRAL VACCINES
WO2014141111A1 (en) 2013-03-14 2014-09-18 Pluristem Ltd. Methods for prevention and treatment of graft-versus-host disease
WO2014201118A2 (en) 2013-06-11 2014-12-18 Sanford-Burnham Medical Research Institute Compositions and methods for targeted endometriosis treatment
SI3016512T1 (sl) 2013-07-05 2020-07-31 H. Lee Moffitt Cancer Center And Research Institute, Inc. Topni CD33 za zdravljenje mielodisplastičnih sindromov (MDS)
US9884895B2 (en) 2014-03-20 2018-02-06 The University Of North Carolina At Chapel Hill Methods and compositions for chimeric coronavirus spike proteins
US10189878B2 (en) 2014-09-24 2019-01-29 University Of Utah Research Foundation Ebolavirus pre-hairpin intermediate mimics and methods of use
EP3247807B1 (en) 2015-01-20 2020-12-16 Adcure Biotechnologies, LLC. Detargeted adenovirus variants and related methods
HK1248554A1 (zh) 2015-02-20 2018-10-19 Board Of Regents, The University Of Texas System 作为疫苗和载体的减毒衣原体的方法和组合物
WO2017040350A1 (en) 2015-08-28 2017-03-09 Navigen, Inc Compositions and methods related to inhibition of respiratory syncytial virus entry
CN109069577B (zh) 2016-01-07 2022-08-19 纳维根公司 Hiv进入的d-肽抑制剂以及使用方法
CN115010808A (zh) 2016-03-16 2022-09-06 阿贝奥姆公司 针对il-25的中和单克隆抗体及其用途
WO2017214197A1 (en) 2016-06-06 2017-12-14 University Of Central Florida Research Foundation, Inc. Combination therapy to improve brain function or promote neurogenesis for treating neurodegenerative conditions
EP3490574B8 (en) 2016-07-29 2024-07-10 Ohio State Innovation Foundation Expression of pten-long with oncolytic viruses
JP7239179B2 (ja) 2016-10-05 2023-03-14 ユニバーシティ オブ セントラル フロリダ リサーチ ファウンデーション,インコーポレイテッド Nk細胞および抗pdl1による癌治療法に関連する方法および組成物
CA3057211A1 (en) 2017-02-28 2018-09-07 University Of Central Florida Research Foundation, Inc. Pm21 particles to improve bone marrow homing of nk cells
EP4215201A1 (en) 2017-03-24 2023-07-26 Ohio State Innovation Foundation Novel recombinant adeno-associated viral vectors restricting off-target transduction in liver and uses thereof
EP3600398B1 (en) 2017-03-28 2023-09-13 Ohio State Innovation Foundation Human pd1 peptide vaccines and uses thereof
US20230140818A1 (en) 2017-04-27 2023-05-04 The University Of Hong Kong Use of hcn inhibitors for treatment of cancer
IL270876B2 (en) 2017-05-25 2024-06-01 Univ Central Florida Res Found Inc Novel oncolytic viruses for sensitizing tumor cells to killing by natural killer cells
US20200225244A1 (en) 2017-09-26 2020-07-16 Sanford Burnham Prebys Medical Discovery Institute Compositions and methods for assessing painful demyelinating and nondemyelinating diseases
CN111479575B (zh) 2017-12-13 2024-03-22 北卡罗莱纳州立大学 包含化疗剂和检查点抑制剂的组合物及使用方法
CN112135639B (zh) 2018-04-06 2023-10-20 北卡罗莱纳州立大学 细胞组装介导的癌症免疫治疗检查点抑制剂的递送
US11717551B2 (en) 2018-05-07 2023-08-08 Georgia State University Research Foundation, Inc. Compositions and methods related to Rhamnus prinoides (GESHO) extract for the inhibition of polymicrobial biofilm formation
BR112020023232A2 (pt) 2018-05-16 2021-02-23 Research Institute At Nationwide Children's Hospital geração de células nk humanas expandidas e primárias de knock-out com o uso de ribonucleoproteínas cas9
US12453743B2 (en) 2018-05-30 2025-10-28 Direct Biologics, Llc Mesenchymal stem cell (MSC) growth factor and extracellular vesicle preparation in frozen or powdered form and methods of use
CA3104664A1 (en) 2018-06-29 2020-01-02 North Carolina State University In situ sprayed bioresponsive immunotherapeutic gel for post-surgical treatment
US11331269B2 (en) 2018-09-06 2022-05-17 Massachusetts Institute Of Technology Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment
EP3847650A1 (en) 2018-09-06 2021-07-14 The Broad Institute, Inc. Nucleic acid assemblies for use in targeted delivery
EP4588483A3 (en) 2018-10-03 2025-09-24 University of Pittsburgh- Of the Commonwealth System of Higher Education Covalent adaptor synnotch and chimeric antigen receptors (cars) for programmable antigen-targeting
WO2020092057A1 (en) 2018-10-30 2020-05-07 Yale University Compositions and methods for rapid and modular generation of chimeric antigen receptor t cells
WO2020093035A1 (en) 2018-11-02 2020-05-07 The Johns Hopkins University Adenoviral chimeric tdp-43 proteins
WO2020161686A1 (en) 2019-02-09 2020-08-13 King Abdullah University Of Science And Technology Compositions and methods for cancer diagnosis and prognosis
KR20220044490A (ko) 2019-06-21 2022-04-08 백시넥스 인코포레이티드 세마포린-4d 차단(sema4d) 및 dc1 요법을 사용한 조합 요법
US12213995B2 (en) 2019-07-18 2025-02-04 Direct Biologics, Llc Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
EP4135765A4 (en) 2020-04-14 2024-05-08 The Regents of the University of California Pan-coronavirus vaccine compositions
US11225508B1 (en) 2020-09-23 2022-01-18 The University Of North Carolina At Chapel Hill Mouse-adapted SARS-CoV-2 viruses and methods of use thereof
CA3202223A1 (en) 2020-11-27 2022-06-02 General Nanotherapeutics Llc Methods and compositions for treatment of immune-mediated diseases
US20230279442A1 (en) 2021-12-15 2023-09-07 Versitech Limited Engineered cas9-nucleases and method of use thereof
KR102436232B1 (ko) * 2022-01-17 2022-08-25 주식회사 세명하이트 원통형 필터 제조방법 및 이에 따라 제조된 원통형 필터
WO2023173137A1 (en) 2022-03-11 2023-09-14 Yale University Compositions and methods for efficient and stable genetic modification of eukaryotic cells
WO2023220644A1 (en) 2022-05-10 2023-11-16 Yale University Compositions and methods of synthetic ctla-4 tails for reprogramming of car-t cells and enhancement of anti-tumor efficacy
KR102736561B1 (ko) * 2022-06-03 2024-12-02 현대제철 주식회사 전기로
KR102751454B1 (ko) * 2022-06-03 2025-01-10 현대제철 주식회사 전기로
KR102777625B1 (ko) * 2022-07-29 2025-03-11 현대제철 주식회사 전기로
KR102829902B1 (ko) * 2022-07-29 2025-07-04 현대제철 주식회사 전기로
KR102752443B1 (ko) * 2022-08-26 2025-01-09 현대제철 주식회사 전기로
KR102793154B1 (ko) * 2022-08-26 2025-04-07 현대제철 주식회사 전기로
WO2024064824A2 (en) 2022-09-21 2024-03-28 Yale University Compositions and methods for identification of membrane targets for enhancement of nk cell therapy
WO2024102997A1 (en) 2022-11-11 2024-05-16 Peterson Jeff R Gout flare prevention methods using il-1β inhibitors
KR102799788B1 (ko) * 2022-11-29 2025-04-22 현대제철 주식회사 전기로용 저취교반장치 및 이를 포함하는 전기로
WO2024155821A1 (en) 2023-01-18 2024-07-25 Yale University Chimeric antigen receptors (car) with intrinsically disordered regions and methods of use thereof
WO2024226829A2 (en) 2023-04-26 2024-10-31 Yale University Enpp3-binding molecules, compositions formed therefrom, and methods of use thereof for the treatment of cancer
WO2024238656A1 (en) 2023-05-15 2024-11-21 Yale Univeristy Chimeric antigen receptor compositions, car-mast cells formed therefrom, and methods of use thereof
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers
WO2025158400A1 (en) 2024-01-24 2025-07-31 Yale University Compositions and methods of natural killer cell hyperboosts for enhancement of nk cell therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US848422A (en) * 1905-06-23 1907-03-26 Frank Wynne Method of maintaining or increasing the fluidity of molten or semimolten materials by means of electricity.
US1339428A (en) * 1916-03-24 1920-05-11 Ludlum Electric Furnace Corp Method of operating an electric furnace

Also Published As

Publication number Publication date
DE1952407A1 (de) 1970-08-20
BE739974A (Direct) 1970-03-16
BR6913348D0 (pt) 1973-01-02
GB1252310A (Direct) 1971-11-03
ES372628A1 (es) 1971-11-01
DE1952407B2 (de) 1971-03-11
US3610795A (en) 1971-10-05
SE364311B (Direct) 1974-02-18
JPS4829422B1 (Direct) 1973-09-10
FR1601438A (Direct) 1970-08-24

Similar Documents

Publication Publication Date Title
FR1601438A (Direct)
AU1946070A (Direct)
AU428130B2 (Direct)
AU2374870A (Direct)
AU416157B2 (Direct)
AU2581067A (Direct)
AU2952567A (Direct)
AU421558B1 (Direct)
AU2580267A (Direct)
AR203075Q (Direct)
AU3789668A (Direct)
AU3224368A (Direct)
BE710792A (Direct)
AU3083868A (Direct)
BE727300A (Direct)
BE726987A (Direct)
BE709274A (Direct)
BE726903A (Direct)
BE726790A (Direct)
BE726753A (Direct)
BE726631A (Direct)
BE726514A (Direct)
BE726466A (Direct)
BE709301A (Direct)
BE709820A (Direct)